White Paper | 2018 Annual Meeting – Panel 3 | Real-Time Oncology Review and the Assessment Aid: Increasing Review Efficiency Through Standardization and Earlier Data Access | November 16, 2018 Share
White Paper | 2018 Annual Meeting – Panel 2 | Exploring the Use of Circulating Tumor DNA as a Monitoring Tool for Drug Development | November 16, 2018 Share
White Paper | 2018 Annual Meeting – Panel 1 | Exploring Whether A Synthetic Control Arm can be Derived from Historical Clinical Trials that Match Baseline Characteristics and Overall Survival Outcome of a Randomized Control Arm | November 16, 2018 Share
White Paper | 2017 Annual Meeting | Data Generation to Support Cross-labeling of Indications for Combination Products | December 12, 2017 Share
White Paper | 2017 Annual Meeting | Capitalizing on the Totality of Evidence to Streamline Approvals for Supplemental Indications | December 6, 2017 Share
White Paper | 2016 Annual Meeting | Optimization of Exploratory Randomized Trials | December 13, 2016 Share
White Paper | 2016 Annual Meeting | Examining the Feasibility of Real World Evidence Through Pilot Studies | December 13, 2016 Share
